Synthesis of chiral 1,4-disubstituted-1,2,3-triazole derivatives from amino acids

Molecules

Volumn 14, Issue 12, 2009, Pages 5124-5143

  Klein, Michael ^a   Krainz, Karin ^a   Redwan, Itedale Namro ^a   Dinér, Peter ^a   Grøtli, Morten ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

1,4 disubstituted 1,2,3 triazoles; 3+2 cycloaddition; Azido alcohols

Indexed keywords

AMINO ACID; TRIAZOLE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOISOMERISM; SYNTHESIS; THIN LAYER CHROMATOGRAPHY;

AMINO ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; STEREOISOMERISM; TRIAZOLES;

EID: 73849092892     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14125124     Document Type: Article

References (39)

1. Fan, W.Q.; Katritzky, A.R. 1,2,3 Triazoles. In Comprehensive Heterocycle Chemistry II; Katritzky, A.R., Rees, C.W., Scriven, E.F.V., Eds.; Pergamon Press: New York, NY, USA, 1996; Vol. pp. 1-126.
2. Katritzky, A.R.; Zhang, Y.; Singh, S.K. 1,2,3-Triazole formation under mild conditions via 1,3-dipolar cycloaddition of acetylenes with azides. Heterocycles 2003, 60, 1225-1239.
3. Alvarez, R.; Velazquez, S.; San, R.; Aquaro, S.; De, C.E.; Perno, C.F.; Karlsson, A.; Balzarini, J.; Camarasa, M.J. 1,2,3-Triazole-[2′,5′- bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3′-spiro-5"- (4"-amino-1″,2″-oxathiole 2″,2″-dioxide) (TSAO) analogues: Synthesis and anti-HIV-1 activity. J. Med. Chem. 1994, 37, 4185-4194.
4. Velazquez, S.; Alvarez, R.; Perez, C.; Gago, F.; De C.E.; Balzarini, J.; Camarasa, J.M. Regiospecific synthesis and anti-human immunodeficiency virus activity of novel 5-substituted N-alkylcarbamoyl and N, N-dialkylcarbamoyl 1,2,3-triazole-TSAO analogues. Antiviral Chem. Chemother. 1998, 9, 481-489.
5. Whiting, M.; Muldoon, J.; Lin, Y.C.; Silverman, S.M.; Lindstrom, W.; Olson, A.J.; Kolb, H.C.; Finn, M.G.; Sharpless, B.K.; Elder, J.H.; Fokin, V.V. Inhibitors of HIV-1 protease by using in situ click chemistry. Angew. Chem. Int. Ed. 2006, 45, 1435-1439.
6. Brik, A.; Muldoon, J.; Lin, Y.C.; Elder, J.C.; Goodsell, D.S.; Olson, A.J.; Fokin, V.V.; Sharpless, B.K.; Wong, C.H. Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors. Chem. Bio. Chem. 2003, 4, 1246-1248.
7. Genin, M.J.; Allwine, D.A.; Anderson, D.J.; Barbachyn, M.R.; Emmert, D.M.; Garmon, S.A.; Graber, D.R.; Grega, K.C.; Hester, J.B.; Hutchinson, D.K.; Morris, J.; Reischer, R.J.; Ford, C.W.; Zurenko, G.E.; Hamel, J.C.; Schaadt, R.D.; Stapert, D.; Yagi, B.H. Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. J. Med. Chem. 2000, 43, 953-970.
8. Brockunier, L.L.; Parmee, E.R.; Ok, H.O.; Candelore, M.R.; Cascieri, M.A.; Colwell, L.F.; Deng, L.; Feeney, W.P.; Forrest, M.J.; Hom, G.J.; MacIntyre, D.E.; Tota, L.; Wyvratt, M.J.; Fisher, M. H.; Weber, A.E. Human beta3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides. Bioorg. Med. Chem. Lett. 2000, 10, 2111-2114.
9. Pande, V.; Ramos, M.J. Structural basis for the GSK-3beta binding affinity and selectivity against CDK-2 of 1-(4-aminofurazan-3yl)-5- dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic acid derivatives. Bioorg. Med. Chem. Lett. 2005, 15, 5129-5135.
10. Olesen, P.H.; Sørensen, A.R.; Ursö, B.; Kurtzhals, P.; Bowler, A.N.; Ehrbar, U.; Hansen, B.F. Synthesis and in vitro characterization of 1-(4-Aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2, 3]triazole-4-carboxylic acid derivatives. A new class of selective GSK-3 Inhibitors. J. Med. Chem. 2003, 46, 3333-3341.
11. Krasinski, A.; Radic, Z.; Manetsch, R.; Raushel, J.; Taylor, P.; Sharpless, B.K.; Kolb, H.C. In situ selection of lead compounds by click chemistry: Target-guided optimization of aceylcholinesterase inhibitors. J. Am. Chem. Soc. 2005, 127, 6686-6692.
12. Mocharla, V.P.; Colasson, B.; Lee, L.V.; Roeper, S.; Sharpless, B.K.; Wong, C.H.; Kolb, H.C. In situ click chemistry: Enzyme-generated inhibitors of carbonic anhydrase II. Angew. Chem. Int. Ed. 2005, 44, 116-120.
13. Micetich, R.G.; Maiti, S.N.; Spevak, P.; Hall, T.W.; Yamabe, S.; Ishida, N.; Tanaka, M.; Yamazaki, T.; Nakai, A.; Ogawa, K. Synthesis and. beta.-lactamase inhibitory properties of beta.-[(1,2,3-triazol-1-yl)methyl]-2. alpha.-methylpenam-3.alpha.-carboxylic acid 1,1-dioxide and related triazolyl derivatives. J. Med. Chem. 1987, 30, 1469-1474.
14. Actor, P.; Uri, J.V.; Phillips, L.; Sachs, C.S.; Zajac, J.R.G.; Berges, D.A.; Dunn, G.L.; Hoover, J.R.E.; Weisbach, J.A. Laboratory studies with cefatrizine (SK + F 60771), a new broad-spectrum orally-active cephalosporin. J. Antibiot. 1975, 28, 594-601.
15. Sidwell, R.W.; Huffman, J.H.; Khare, G.P.; Allen, L.B.; Witkowski; J.T.; Robins, R.K. Broad-spectrum antiviral activity of Virazole: 1-Beta-D- ribofuranosyl-1,2,4-triazole-3-carboxamide. Science 1972, 177, 705-706.
16. Terasaka, T.; Kinoshita, T.; Kuno, M.; Nakanishi, I. A highly potent non-nucleoside adenosine deaminase inhibitor: Efficient drug discovery by intentional lead hybridization, J. Am. Chem. Soc. 2004, 126, 34-35.
17. Terasaka, T.; Kinoshita, T.; Kuno, M.; Seki, N.; Tanaka, K.; Nakanishi, I. Structure-based design, synthesis, and structure-activity relationship studies of novel non-nucleoside adenosine deaminase inhibitors. J. Med. Chem. 2004, 47, 3730-3743.
18. Terasaka, T.; Okumura, H.; Tsuji, K.; Kato, T.; Nakanishi, I.; Kinoshita, T.; Kato, Y.; Kuno, M.; Seki, N.; Naoe, Y.; Inoue, T.; Tanaka, K.; Nakamura, K. Structure-based design and synthesis of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors. J. Med. Chem. 2004, 47, 2728-2731.
19. Terasaka, T.; Tsuji, K.; Kato, T.; Nakanishi, I.; Kinoshita, T.; Kato, Y.; Kuno, M.; Inoue, T.; Tanaka, K.; Nakamura, K. Rational design of non-nucleoside, potent, and orally bioavailable adenosine deaminase inhibitors: predicting enzyme conformational change and metabolism. J. Med. Chem. 2005, 48, 4750-4753.
20. Benarroch, D.; Egloff, M.P.; Mulard, L.; Guerreiro, C.; Romette, J.L.; Canard, B. A structural basis for the inhibition of the NS5 dengue virus mRNA 2?-O-methyltransferase domain by ribavirin 5?-triphosphate. J. Biol. Chem. 2004, 279, 35638-35643.
21. Tornøe, C.; Christensen, C.; Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(I)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. 2002, 67, 3057-3064.
22. Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, B.K. A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective ligation of azides and terminal alkynes. Angew. Chem. Int. Ed. 2002, 41, 2596-2599.
23. Laufer, S.A.; Domeyer, D.M.; Scior, T.R.F.; Albrecht, W.; Hauser, D.R.J. Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors. J. Med. Chem. 2005, 48, 710-722.
24. Zaloom, J.; Roberts, D.C. Preparation of azido derivatives from amino acids and peptides by diazo transfer. J. Org. Chem. 1981, 46, 5173-5176.
25. Vasella, A.; Witzig, C.; Chiara, J.L.; Lomas, M.M. Convenient synthesis of 2-Azido-2-deoxy-aldoses by diazo transfer. Helv. Chim. Acta 1991, 74, 2073-2077.
26. 2O]Ala Containing Analogue of the Drug Desmopressin. Bioorg. Med. Chem. Lett. 2002, 12, 841-844.
27. Hedenström, M.; Yuan, Z.; Brickmann, K.; Carlsson, J.; Ekholm, K.; Johansson, B.; Kreutz, E.; Nilsson, A.; Sethson, I.; Kihlberg, J. Conformations and receptor activity of desmopressin analogues, which contain gamma-turn mimetics or a psi[CH(2)O] isostere. J. Med. Chem. 2002, 45, 2501-2511.
28. Ramanathan, S.K.; Keeler, J.; Lee, H.L.; Reddy, D.S.; Lushington, G.; Aube, J. Modular synthesis of cyclic peptidomimetics inspired by γ-turns. Org. Lett. 2005, 7, 1059-1062.
29. Gerard, B.; Ryan, J.; Beeler, A.B.; Porco, J.A., Jr. Synthesis of 1,4,5-trisubstituted-1,2,3-triazoles by copper-catalyzed cycloaddition-coupling of azides and terminal. Tetrahedron 2006, 62, 6405-6411.
30. Wang, Q.; Chan, T.R.; Hilgraf, R.; Fokin, V.V.; Sharpless, B.K.; Finn, M.G. Bioconjugation by copper(I)-catalyzed azide-alkyne [3+2] cycloaddition. J. Am. Chem. Soc. 2003, 125, 3192-3193.
31. Himo, F.; Lovell, T.; Hilgraf, R.; Rostovtsev, V.V.; Noodleman, L.; Sharpless, B.K.; Fokin, V.V. Copper(I)-catalyzed synthesis of azoles. DFT study predicts unprecedented reactivity and intermediates. J. Am. Chem. Soc. 2005, 127, 210-216.
32. Chan, T.R.; Hilgraf, R.; Sharpless; B.K.; Fokin, V.V. Polytriazoles as copper(I)-stabilizing ligands in catalysis. Org. Lett. 2004, 6, 2853-2855.
33. Merlo, A.A.; Fernandes, M.S. An efficient strategy for the synthesis of chiral liquid crystals using Evans' methodology. Synth. Commun. 2003, 33, 1167-1178.
34. Park, C.S.; Kim, M.S.; Sim, T.B.; Pyun, D.K.; Lee, C.H.; Choi, D.; Lee, W.K.; Chang, J.W.; Ha, H.J. Novel stereoselective synthesis of functionalized oxazolidinones from chiral aziridines. J. Org. Chem. 2003, 68, 43-49.
35. Welch J.T.; Seper, K.W. Synthesis, regioselective deprotonation, and stereoselective alkylation of fluoro ketimines. J. Org. Chem. 1988, 53, 2991-2999.
36. Danklmaier, J.; Hoenig, H. Synthese diastereomerenreiner 2,5-disubstituierter 3-Oxoperhydro-1,4-oxazine. Liebigs Ann. Chem. 1988, 851-854.
37. Macromodel [1]; Schrödinger, LLC: New York, NY, USA, 2007.
38. Glide [0]; Schrödinger, LLC: New York, NY, USA, 2005.
39. Friesner, R.A.; Murphy, R.B.; Repasky, M.P.; Frye, L.L.; Greenwood, J.R.; Halgren, T.A.; Sanschagrin, P.C.; Mainz, D.T. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem. 2006, 49, 6196.